Seven Bridgesvs
AWS (Amazon Web Services)
AWS (Amazon Web Services): If you have the security engineering capacity to build and certify the environment yourself and want to avoid a platform subscription
Seven Bridges
Cloud bioinformatics platform and trusted research environment, sold by Velsera
As of 31 August 2026, Seven Bridges's pricing is not published; the vendor quotes on request. A genomics analysis platform for running and developing pipelines on cloud infrastructure, still sold under the Seven Bridges name after its parent merged into Velsera. Softwr lists it under Research. Seven Bridges is made by Velsera, available on Web, API, Cloud.
Overview
What Seven Bridges does
The Seven Bridges Platform is a cloud environment for bioinformatic analysis and pipeline development, presented as a trusted research environment. Researchers build and run workflows in Common Workflow Language against very large genomic datasets without provisioning infrastructure, and the platform is cloud-agnostic, bringing analysis to where the data already sits rather than requiring bulk transfer. It underpins several major public data commons, including the Cancer Genomics Cloud, which is the clearest signal of what it is designed for. The reason institutional buyers choose it is the compliance surface rather than the analysis features, which have credible open source equivalents. The platform carries FedRAMP Moderate, SOC 2, HIPAA, GDPR, dbGaP and a stack of ISO certifications including 27001, 27017, 27018 and 27701. For a group working with controlled-access human genomic data under a data use agreement, that paperwork is the product; assembling the equivalent on raw cloud infrastructure is a year of security engineering that no research budget wants to fund. Ownership has changed and matters. Seven Bridges was acquired by Summa Equity in 2023 and merged with Pierian and UgenTec to form Velsera, which sells the platform alongside clinical interpretation and diagnostics products. The Seven Bridges brand survived the merger and is still actively sold. Pricing is not published, and the practical cost model is a platform subscription plus cloud compute and storage that scales with what you actually run, which means budget forecasting depends on analysis volume more than on headcount.
What people use it for
- A cancer genomics group analysing controlled-access dbGaP data that cannot be moved to local infrastructure
- A federal or federally funded programme that needs FedRAMP Moderate authorisation for its analysis environment
- A multi-institution consortium sharing pipelines and results under defined access controls rather than by emailing files
- A diagnostics developer building reproducible CWL pipelines that must stand up to later regulatory review
Related searches
The honest half
Where it falls short
Concrete and checkable, so you can decide whether any of them matter to you. This is the half of a review a vendor will not write about Seven Bridges.
- The parent merged into Velsera in 2023 alongside Pierian and UgenTec, so the platform now competes for roadmap attention with clinical interpretation and diagnostics products inside a private equity owned group.
- Pricing is not published and splits into a platform subscription plus consumption-based cloud compute, so a heavy analysis quarter produces a bill that headcount-based budgeting does not anticipate.
- The analysis capability itself has credible open source equivalents in Nextflow and Cromwell on raw cloud, so you are principally paying for compliance and governance rather than for the science.
- Pipelines are built around Common Workflow Language, which is a real learning curve and a portability commitment for teams whose existing work is in other workflow languages.
- Cloud storage of large genomic datasets accrues continuously whether or not you are analysing, and egress charges apply when moving results out, both of which are outside the subscription line.
Cross-shopped
What people choose instead of Seven Bridges
Each pairing was judged by two reviewers asking whether a buyer would genuinely weigh the two against each other. The ones that failed were deleted rather than published.
- Seven BridgesvsDomino Data Lab
Domino Data Lab: A general research computing platform if your work is not specifically genomic pipeline execution
- Seven BridgesvsDatabricks
Databricks: Better fit when the workload is large-scale data engineering and analytics rather than CWL bioinformatics pipelines
Pricing
What Seven Bridges costs
Taken from the vendor's own pricing page. Prices move, so check before you buy.
Seven Bridges Platform
On request
- Platform subscription quoted through Velsera sales
- Cloud compute and storage charged on consumption on top of the subscription
- Cost predictor tools provided to estimate analysis spend in advance
- Compliance certifications included rather than sold as a premium tier
- Academic and consortium arrangements negotiated separately
Capabilities
Features
Trusted research environment
Controlled-access analysis with certified security and governance controls
Cloud-agnostic
Analysis brought to the data across multiple cloud providers
CWL pipelines
Workflow development and execution in Common Workflow Language
Compliance certifications
FedRAMP Moderate, SOC 2, HIPAA, GDPR, dbGaP and ISO 27001, 27017, 27018 and 27701
Cost prediction
Tools to estimate compute spend before running an analysis
Public data commons
Powers environments including the Cancer Genomics Cloud
Collaboration
Shared projects across institutions under defined access controls
Tool library
Prebuilt and containerised bioinformatics tools ready to compose
Answered, with sources
Questions people ask
Each answer names the page it came from, so you can check it rather than take our word for it.
Is Seven Bridges still sold?
Yes. It is sold by Velsera, formed in 2023 when Summa Equity merged Seven Bridges with Pierian and UgenTec. The Seven Bridges name was retained for the platform.
What compliance does it hold?
FedRAMP Moderate, SOC 2, HIPAA, GDPR, dbGaP and ISO 27001, 27017, 27018 and 27701, which is the usual reason institutions choose it over building on raw cloud.
How is it priced?
Not published. Expect a platform subscription plus consumption charges for cloud compute and storage.
Do I have to use a specific cloud?
No. The platform is cloud-agnostic and designed to bring analysis to where the data already resides.
Keep looking
Where to go from Seven Bridges
- Seven Bridges alternativesEvery product people weigh against it
- Seven Bridges pricingPlans, floors and what the tiers exclude
- Seven Bridges badgesWhich rules it meets, and the figure behind each
- All Research softwareThe full category
- Best Research softwareThe shortlist, and how it was cut
Best Research software for
Compare Seven Bridges with
- DNAnexus
- Terra
- Dotmatics
- Form Bio
- Labguru
- Chemaxon
- Genedata
- Greenphire
- Medidata Rave
- OpenEye, Cadence Molecular Sciences
- Attest
- NVivo
- Schrodinger
- Scispot
- Suzy
- TetraScience
- Thermo SampleManager LIMS
- Terra
Other Research software
Regulated cloud platform for genomic and multiomic data, with GxP and FedRAMP coverage
Pricing on request10 researched notesOpen biomedical research platform for genomic analysis, priced only by the cloud you consume
Open source12 researched notesResearch informatics group behind GraphPad Prism, SnapGene, Geneious and LabArchives, now owned by Siemens
Pricing on request12 researched notesComputational platform for cell and gene therapy design and manufacturability
Pricing on request10 researched notesElectronic lab notebook, LIMS and inventory in one system, now sold under the Cenevo group
Pricing on request12 researched notesCheminformatics toolkits and structure handling, now a Certara subsidiary
Pricing on request12 researched notesEnterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher
Pricing on request12 researched notesClinical trial participant payments, reimbursement and travel, now part of Suvoda
Pricing on request9 researched notesElectronic data capture for regulated clinical trials, sold only through a sales process
Pricing on request9 researched notesComputational chemistry toolkits and the Orion cloud platform, now inside Cadence
Pricing on request9 researched notesPhysics based molecular modelling and drug discovery software, licensed by token pool
Pricing on request10 researched notesNo-code lab operating system combining LIMS, ELN and inventory for biotech teams
Pricing on request12 researched notesEnterprise consumer insights on an owned US panel, resold elsewhere through Cint
Pricing on request14 researched notesScientific data cloud that harmonises instrument output across the lab estate
Pricing on request12 researched notesEnterprise LIMS for regulated QC laboratories, with LES and SDMS in one product
Pricing on request12 researched notesOpen biomedical research platform for genomic analysis, priced only by the cloud you consume
Open source12 researched notes
Softwr does not host reviews and shows no star rating for Seven Bridges, because a rating we did not collect is not ours to publish. What is here is the pricing and platform detail from the vendor’s own pages, limitations we could state concretely, and alternatives a reviewer confirmed people weigh against it. Tell us if any of it is wrong.
More on Seven Bridges
Seven Bridges alternatives
What people switch to, and what they give up
Seven Bridges pricing
Every tier, and where the cost actually lands
Compare Seven Bridges
Put it head to head with anything we hold
Seven Bridges badge
Its rating, and an embed for your own site
Best Research software alternatives
Science-aware laboratory platform combining LIMS, ELN and scientific data management
quote
R&D cloud for biotechnology research and molecular biology
Free for academics, quoted for organisations
UX research repository for tagging notes, building insights and finding them again years later
Flat monthly fee, unlimited users
Electronic data capture and eConsent for clinical trials, built for investigator-initiated studies as well as sponsors
quote
